{
    "SPADE_N_14547": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14547",
            "Peptide Name": "LM9 (Lactomodulin fragment, Synthetic AMPs, XXA, UCLL1c)",
            "Source": "sequence truncation, bacteria-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "HADELVAGVKQ",
            "Sequence Length": 11,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1166.28,
            "PI": 5.32,
            "Hydrophobicity": -0.2,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Mousa WK, Shaikh AY, Ghemrawi R, Aldulaimi M, Al Ali A, Sammani N, Khair M, Helal MI, Al-Marzooq F, Oueis E. 2024",
                    "Reference": "RSC Med Chem. 2024 Oct 28. doi: 10.1039/d4md00383g.PubMed",
                    "Title": "Human microbiome derived synthetic antimicrobial peptides with activity against Gram-negative, Gram-positive, and antibiotic resistant bacteria."
                }
            ],
            "Frequent Amino Acids": "AVD",
            "Absent Amino Acids": "CFIMNOPRSTUWY",
            "Basic Residues": 2,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 5,
            "Polar Residues": 7,
            "Positive Residues": 2,
            "Negative Residues": 2,
            "Net Charge": 0,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (42.86%) toMyxinidin Y8AL=G=S=E=K: 15%.Activity: active against S. aureus ATCC 25923 or MRSA BAA 2313 (MIC 1.3-2.5 uM),  C. difficile ATCC 43602 (MIC 1.0 uM), L. monocytogenes ATCC 15313 (MIC 1.1 uM), E. faecium anti-VRE BAA 2317 (MIC 3.1 uM), E.coli ATCC 33694 (NA), P.aeruginosa BAA 1744 (NA), and S.enterica ATCC 13314 (NA). NA: not observed.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14537",
                    "Similarity": 1.0,
                    "Sequence": "MNKLNEVELSKISGGIGPLVIPVAAILGFLATDAWNHADELVAGVKQGWERS"
                },
                {
                    "SPADE_ID": "SPADE_N_14541",
                    "Similarity": 1.0,
                    "Sequence": "DAWNHADELV"
                },
                {
                    "SPADE_ID": "SPADE_UN_26645",
                    "Similarity": 1.0,
                    "Sequence": "DAWNHADELV"
                }
            ]
        }
    }
}